A diagram showing a mitochondrion of the eukaryotic cell. Mitochondria are organelles surrounded by membranes, distributed in the cytosol of most eukaryotic cells. Its main function is the conversion of potential energy of pyruvate molecules into ATP. (Photo credit: Wikipedia)
Scientists have discovered that an active ingredient in an over-the-counter skin cream slows or stops the effects of Parkinson’s disease on brain cells.
The active ingredient in an over-the-counter skin cream might do more than prevent wrinkles. Scientists have discovered that the drug, called kinetin, also slows or stops the effects of Parkinson’s disease on brain cells.
Scientists identified the link through biochemical and cellular studies, but the research team is now testing the drug in animal models of Parkinson’s. The research is published in the August 15, 2013 issue of the journal Cell.
“Kinetin is a great molecule to pursue because it’s already sold in drugstores as a topical anti-wrinkle cream,” says HHMI investigator Kevan Shokat of the University of California, San Francisco. “So it’s a drug we know has been in people and is safe.”
Parkinson’s disease is a degenerative disease that causes the death of neurons in the brain. Initially, the disease affects one’s movement and causes tremors, difficulty walking, and slurred speech. Later stages of the disease can cause dementia and broader health problems. In 2004, researchers studying an Italian family with a high prevalence of early-onset Parkinson’s disease discovered mutations in a protein called PINK1 associated with the inherited form of the disease.
Since then, studies have shown that PINK1 normally wedges into the membrane of damaged mitochondria inside cells that causes another protein, Parkin, to be recruited to the mitochondria, which are organelles responsible for energy generation. Neurons require high levels of energy production, therefore when mitochondrial damage occurs, it can lead to neuronal death. However, when Parkin is present on damaged mitochondria, studding the mitochondrial surface, the cell is able to survive the damage. In people who inherit mutations in PINK1, however, Parkin is never recruited to the organelles, leading to more frequent neuronal death than usual.
Shokat and his colleagues wanted to develop a way to turn on or crank up PINK1 activity, therefore preventing an excess of cell death, in those with inherited Parkinson’s disease. But turning on activity of a mutant enzyme is typically more difficult than blocking activity of an overactive version.
“When we started this project, we really thought that there would be no conceivable way to make something that directly turns on the enzyme,” says Shokat. “For any enzyme we know that causes a disease, we have ways to make inhibitors but no real ways to turn up activity.”
His team expected it would have to find a less direct way to mimic the activity of PINK1 and recruit Parkin. In the hopes of more fully understanding how PINK1 works, they began investigating how PINK1 binds to ATP, the energy molecule that normally turns it on. In one test, instead of adding ATP to the enzymes, they added different ATP analogues, versions of ATP with altered chemical groups that slightly change its shape. Scientists typically must engineer new versions of proteins to be able to accept these analogs, since they don’t fit into the typical ATP binding site. But to Shokat’s surprise, one of the analogs—kinetin triphosphate, or KTP—turned on the activity of not only normal PINK1, but also the mutated version, which doesn’t bind ATP.
“This drug does something that chemically we just never thought was possible,” says Shokat. “But it goes to show that if you find the right key for the right lock, you’ll be able to open the door.”
To test whether the binding of KTP to PINK1 led to the same consequences as the usual ATP binding, Shokat’s group measured the activity of PINK1 directly, as well as the downstream consequences of this activity, including the amount of Parkin recruited to the mitochondrial surface, and the levels of cell death. Adding the precursor of KTP, kinetin, to cells—both those with PINK1 mutations and those with normal physiology—amplified the activity of PINK1, increased the level of Parkin on damaged mitochondria, and decreased levels of neuron death, they found.
“What we have here is a case where the molecular target has been shown to be important to Parkinson’s in human genetic studies,” says Shokat. “And now we have a drug that specifically acts on this target and reverses the cellular causes of the disease.”
The Latest Bing News on:
Parkinson’s Disease
- Parkinson's disease is an ailment that impacts the central nervous system.on May 19, 2022 at 11:32 pm
Previous studies have shown that Covid-19 impacts the human brain in a myriad of ways. Lingering effects of the ailment can cause brain fog, lead to structural changes, mood swings, anxiety and even ...
- ‘Sting’ protein’s response to clean up damaged brain cells may accelerate Parkinson’s disease progressionon May 19, 2022 at 6:07 pm
In studies with mouse and human tissue, as well as live mice, Johns Hopkins Medicine researchers report that a snag in the normal process of cleaning up broken DNA in brain cells may hasten the ...
- 'STING' protein's efforts to clean up brain cell damage may speed Parkinson's disease progresson May 19, 2022 at 12:44 pm
In studies with mouse and human tissue, as well as live mice, Johns Hopkins Medicine researchers report that a snag in the normal process of cleaning up broken DNA in brain cells may hasten the ...
- COVID-19 may increase risk of Parkinson's disease, study findson May 19, 2022 at 6:48 am
A new study conducted by researchers from Thomas Jefferson University explored how COVID-19 may affect brain health long-term. According to the findings, t ...
- Silo Pharma Announces Successful Dosing of Patients Suffering from Parkinson’s Disease in ...on May 19, 2022 at 5:11 am
Study is examining effects of Psilocybin on Inflammatory Markers ENGLEWOOD CLIFFS, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc . (OTCQB: SILO), a development-stage biopharmaceutical compan ...
- Larimar Therapeutics Announces Upcoming Poster Presentations at the 4th Pan American Parkinson’s Disease and Movement Disorders Congresson May 19, 2022 at 5:00 am
Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that data from the Company’s ...
- Link between COVID-19 and Parkinson’s disease risk grows with new findingson May 18, 2022 at 5:32 pm
A few years after the 1918 Spanish Flu pandemic doctors around the world began to notice an increase in new Parkinson’s disease cases. This link between viral infection and increased Parkinson’s risk ...
- Study in mice suggests that COVID-19 increases risk of developing Parkinson's diseaseon May 18, 2022 at 12:54 pm
Brain fog, headaches, and insomnia are some of the neurological symptoms doctors have observed in COVID-19 patients. Neurological sequelae after a viral infection is not new—in fact, following the ...
- Research Confirms Patients with Essential Tremor and Parkinson’s Disease Have Higher Comorbidities and Costson May 18, 2022 at 9:15 am
Cala Health, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced new clinical research presented at ISPOR 2022.
- New powerful MRI scanners may help to treat Parkinson's disease betteron May 18, 2022 at 9:14 am
New treatment options for neuronal diseases require better imaging techniques that will help find which patients will benefits from these treatments ...
The Latest Google Headlines on:
Parkinson’s Disease
The Latest Bing News on:
Kinetin
- Vitamins & Supplements Centeron August 16, 2020 at 1:05 pm
Considering taking a vitamin or supplement to treat Aging+Skin? Below is a list of common natural remedies used to treat or reduce the symptoms of Aging+Skin. Follow the links to read common uses ...
- Vol. 57, No. 1, Jan., 1976on July 16, 2017 at 10:27 pm
80-84) Stimulation of Ethylene Production in the Mung Bean Hypocotyls by Cupric Ion, Calcium Ion, and Kinetin Stimulation of Ethylene Production in the Mung Bean Hypocotyls by Cupric Ion, Calcium Ion, ...
- Vol. 41, No. 174, July 1977on June 13, 2017 at 10:24 pm
747-753) Effects of Kinetin on Growth of the Apical Meristem and Floral Differentiation in Chenopodium rubrum L. Effects of Kinetin on Growth of the Apical Meristem and Floral Differentiation in ...
- Pollinating Sprays for Vegetable Gardenson May 27, 2015 at 6:35 am
These sprays contain kinetin, a variety of the cytokinin hormone. Kinetin is a synthetic compound that fosters cytokinesis or cell division. Pollinating sprays cause fruit to develop even when the ...
- Vitamins & Supplements Centeron February 20, 2015 at 5:20 pm
Considering taking a vitamin or supplement to treat Wrinkled+Skin? Below is a list of common natural remedies used to treat or reduce the symptoms of Wrinkled+Skin. Follow the links to read common ...